MEDIGUS LTD - SPON ADR (MDGS) Stock Price & Overview
NASDAQ:MDGS • US58471G4091
Current stock price
The current stock price of MDGS is 2.36 USD. Today MDGS is up by 8.28%. In the past month the price decreased by -13.24%. In the past year, price decreased by -55.13%.
MDGS Key Statistics
- Market Cap
- 4.471M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -6.98
- Dividend Yield
- 29.82%
MDGS Stock Performance
MDGS Stock Chart
MDGS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to MDGS. When comparing the yearly performance of all stocks, MDGS is a bad performer in the overall market: 93.45% of all stocks are doing better.
MDGS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MDGS. MDGS has a bad profitability rating. Also its financial health evaluation is rather negative.
MDGS Earnings
MDGS Forecast & Estimates
For the next year, analysts expect an EPS growth of 25.58% and a revenue growth 25.68% for MDGS
MDGS Groups
Sector & Classification
MDGS Financial Highlights
Over the last trailing twelve months MDGS reported a non-GAAP Earnings per Share(EPS) of -6.98. The EPS decreased by -116% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.49% | ||
| ROE | -41.78% | ||
| Debt/Equity | 0.11 |
MDGS Ownership
MDGS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.66 | 188.521B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.96 | 169.656B | ||
| SYK | STRYKER CORP | 22.46 | 132.338B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.99 | 105.772B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.37 | 47.98B | ||
| IDXX | IDEXX LABORATORIES INC | 39.12 | 45.95B | ||
| BDX | BECTON DICKINSON AND CO | 11.48 | 45.012B | ||
| RMD | RESMED INC | 18.52 | 33.198B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.62 | 32.016B | ||
| DXCM | DEXCOM INC | 26.46 | 26.04B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.6 | 17.429B | ||
| HOLX | HOLOGIC INC | 15.35 | 16.777B | ||
| PODD | INSULET CORP | 35.36 | 16.212B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MDGS
Company Profile
Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)
Company Info
IPO: 2006-02-27
MEDIGUS LTD - SPON ADR
10 HaNechoshet Street
TEL AVIV-YAFO IL
Employees: 77
Phone: 972722602211
MEDIGUS LTD - SPON ADR / MDGS FAQ
What does MDGS do?
Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)
Can you provide the latest stock price for MEDIGUS LTD - SPON ADR?
The current stock price of MDGS is 2.36 USD. The price increased by 8.28% in the last trading session.
Does MEDIGUS LTD - SPON ADR pay dividends?
MEDIGUS LTD - SPON ADR (MDGS) has a dividend yield of 29.82%. The yearly dividend amount is currently 0.15.
How is the ChartMill rating for MEDIGUS LTD - SPON ADR?
MDGS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.